Member Info for roger65

Sorry * £250K per year.

I wonder at your optimism Tiger, and you're far from being the only poster here who has that kind of belief in GDR's future.

Sadly the company performance to date has been iffy to say the least and I think many would find an offer of 27p hard to decline if it landed right now. Not sure how much retail own of GDR but it's a fair old % so any vote to approve would be tight. Hypothetical I know but sure makes a pleasant change from guessing how low the next major placing is going to be.

As for a sale at £1 per share....? Er nope. Don't see that. That would be selling the company for well above £100m. Company is currently desperate for money and earns £250per year and the mcap is just £8m

As I say, I admire your outlook.

Ats - I think you are right. Any buyout offer must at least match the high of the previous 12months. I Don't know if that's an AIM rule or general stock market rule but it makes sense or companies would constantly being bought up every time they had a dip in share price, even if for a good reason. Stands to reason. And on that basis any such offer today would have to be at about 27p. I wouldn't say no! Now got £35k in at an average of 8.16p I would recover all of my losses and make a small profit. Now wouldn't that be a result after the heart ache lths have been through here. If this does dip significantly further or a placing occurs at 4p or less and retail are invited to participate then I will get my hands on as many shares as I possibly can. Until funding issue is sorted and announced however I will stay the hand at this level.

You're entitled to your opinion Tiger, as am I. I happen to disagree. Since selling out about three weeks ago, when I was still about £75k down. I have now bought back in with an average of just over 8.15p. Already after only 3 days I'm down another 25%. I think the funding issue is far too serious here and there are simply no guarantees of income any time soon. Every time GDR followers think we're nearly there we learn of yet another delay, or condition of more data gathering. It's never a case of simply being given a green light. AIHL had no competition so was given CONDITIONAL recommendation meaning the NHS neonatal units don't have to use it. CYP2C19 does have competition so will be granted (hopefully) FULL recommendation meaning we can sell it but NICE has kindly stated it prefers the NHS to use lab testing. You couldn't make it up the number of times the NHS/NICE seems to either shoot itself in the foot be slowing down progress or making odd decisions. Even if CYP2C19 gets a full recommendation in JULy it will then take at least another 2 years before it can be sold in the US.

So no, I don't think this is about to go on another surge. That happened last week and I suspect was short lived because of forward selling by the placee. If it wasn't then I think Cheek will be kicking himself for not having lined something up and now having to go cap in hand when the sp has dropped back towards 5p.

I'll hang about until we know what the discount will be and just how much dilution there will be. It's going to hurt in the short term but as always I think in a couple of years time things will hopefully start to turn round. Finally.

'The effect of the settlement is that CAP-XX has no litigation matters outstanding and the Board and management can focus fully on continuing to progress the CAP-XX business.'

No one forced the BOD to take on the litigation issues. They called it, went for it and got it wrong, causing huge damage to the company. They're now effectively admitting they've taken their eye off the ball whilst attempting to pursue those legal cases and have put this company in a terrible position. I agree that the 10% of Pis who have large holdings here seem to be very quiet. Too quiet for my liking. Lars has something lined up but I fear it isn't the lining of any retail investors' pockets.

Suspended for nearly two weeks now. Not looking good is it?! Who ever it was that confidently predicted an RNS on Friday or first thing this morning stating suspension over and that there was nothing to worry about got it wrong. Clearly more serious than we have been told.

None of us knows for sure, and assuming a placing price has already been agreed, I wonder how many of us now suspect that rise last week was well overdone by the mms to help the placee get their shares forward sold..?

Trouble for Cheek now is that everyone knows the placing is coming and so buying has suddenly ground to a halt again. He is playing roulette in that he can either wait it out and hope some good news lands very soon and do a placing on the back of another slight rise in the sp or....he can just get it over and done with at a lower price. Speaking for myself I am waiting to know about the placing and if offered the chance to take a chunk at the placing price then I will. Think Cheek might be surprised by how much he could raise from retail if he confirmed RF will take no further part in providing funds. It will spring back up once we start to near in on July NICE news. Would actually help me recover some of the losses I've had from the last few years here.

So Jimi, are you suggesting even if CYP2C19 gains full recommendation from NICE in July there will only be very limited use of the tests throughout the NHS? Ie little revenue for GDR then?

Full or just Final and conditional approval in July for CYP2C19. This is a critical issue for GDR and we need to find out from the horse’s mouth what is expected.

Anyone have any contacts within NICE and in a position to inquire?

The answer will definitely have an impact on the sp over the next 10 - 12 weeks.

Ha! Well it certainly feels like 4 yrs. I do know my first purchases were north of 10p though. More fool me. My point is the same though. Burt needs to prove sales are growing.

OMG who has mentioned 50p? Don't be ridiculous.

HE1 will be doing very well indeed if it gets as high as 5p by the end of this year. It has to do another major placing which means yet more dilution for poor long suffering holders who are mostly still in the red. 50p is just stupid and idiotic. Do you really think the big players in the market would be sitting idle if this had that kind of potential? Nah. Didn't hink so

Watched the presentation again and feeling better than i did on first viewing. Some good points and some bad.

Regarding the Q about taking the company private, on reflection I think Cheek is slightly exasperated by the Q and shows his disdain by simply saying he doesn't want to comment on it. Good.

FDA for CYP2C19 will not achieve sales or revenue in the US until start of 2027. Bad.

More hospitals coming on line with AIHL, albeit slower than we would like. Revenue now coming in from EU and set to increase here at home. Good.

AIHL requires yet more evidence for NICE Full recommendation. Tedious but now not that far off. Revenue from AIHL will slowly increase anyway until we get that green FULL light.

Seems to me Gino didn't completely get the question about CYP2C19 receiving Full recommendation in July. He said yes but I actually think he was confused and said he sees no reason why it should change - I think he was thinking 'FINAL' recommendation. I'd like it to be FULL but can't see for the life of me why the stroke test would be able to circumnavigate all the data gathering evidence saga that has beset AIHL test.

FDA partner to be announced soon once they've signed on the dotted line. This was the scenario last Dec so nothing imv has changed on this and I suspect it revolves around funding being sorted.

We need the raise to be done asap - great that retail investors can participate - so the FDA partner finally commits. Are we in a chicken and egg scenario? Cheek needs a funder to see more confidence and less volatility in the sp to bring them on side but we need some more good news in order to provide that liquidity and sentiment.

Let's see if the two new hospitals taking AIHL are biggies. If they happen to be London ones then so much the better. That will help the sp. Clarification on whether or not CYP2C19 is due for FULL recommendation in July. If that was confirmed that would help too. Significantly. Then the FDA partner might come on board. Even better.

Personally a traditional placing would be great and much better than relying on further drawdowns from RF. Great to hear the BODs clear on their preference NOT to request more funds from RF but in the event it's really needed it's there. Ticks all round.

At the end Cheek says the company is in an excellent position - in a 'brilliant' place. I think he's right but there are two elephants in the room still lurking. Firstly, funding. We are ALL bored of hearing about it and talking about it now so Cheek has to get this sorted as top priority. If at 5p then that's really not so bad. At 4p I think even more retail will take it up. RF will sell their warrants at just over 10p unless the news flow improves hugely and is overwhelmingly positive. Personally I hope he goes for about £3m or £4m offering retail as much as they want. That would see us through to the point where sales of AIHL in the UK and EU and ME, together with a tax R & D rebate, cover annual costs.

So, he can barely hide the fact there have been conversations about taking GDR private but in the same presentation states he wants to give pis a chance to take part in a placing. Classy James. Very classy. Retail investors have been rinsed and shafted repeatedly here and now, in its death throes the CEO suggests pis might like to hand over more cash to send them merrily on their way before they make a fortune on the back of ordinary people. AIM is a totally disgusting and encouraging and rewarding a new breed of businessman where by it is acceptable according to the FCA to deliberately mislead the market - as long as it’s just retail investors of course - and make as much money for themselves as they like.

The longer I think about it the more gutted I feel. Yesterday felt like God news was about to land but today was one of the worst presentations I’ve seen from any AIM outfit. Like it was almost deliberately downbeat and disorganised.

Exactly my feeling Prof but…if that was their intention then why bother with the presentation at all? They didn’t have to. They’ve got enough cash to get them through to July with another couple of drawdowns.

Cheek’s answer to that question though was uncomfortable to say the least!

Diabolical.and the rampers who yesterday were posting ‘this is full recommendation’ were 100% wrong and making it up.

...with a nasty placing being announced at a horribly low price then. Gotta wait for tomorrow to see what Cheek has to say. Also hope a nasty red dot doesn't appear first thing. Would really be typical of my luck with this stock.

I now think Cheek WILL try to wait for good news to up the sp before arranging a placing because that's his best chance of moving the company out of the clutches of RF. If he can raise just £3m even with some fairly hefty dilution I think that will put the company's position into different territory. Perhaps once and for all GDR will be within clear sight of becoming self sufficient going forwards. Hope by the end of the summer??

Totally different circs surrounding the business and the company directors. CPX is worthless and Lars is abysmal and his decisions have put the company on the floor. £2m at a price of .1p isn't something to be impressed by given only a matter of weeks ago the sp was at .6p or higher. He's totally blown it and I suspect there is a plan afoot already to take CPX off his hands for peanuts. If the £2m worth of funding is going to a hostile company then they already have way more votes than they need to approve a sale of the company of say £3m. I suspect the FDA have got wind of something more murky than just the slow settlement of trades and now have to look deeper into what is going on.

Sales figures. All the new placements are very nice but it's sales figures that really count. In fact that's all that matters here in the short/near term. If those are bad then it's going to get even uglier here and highly likely to go bust.

Personally hoping someone somewhere will see it's a good range of products and take it off Burt's mitts for a few £m. £6 to be exact would make up all my losses here after four years of being invested. Flipping hopeless management and CEO.

If you're in here then bad luck. I hope your suffering will be at an end before long.

IG - that's what i thought when the sp was at 3.5p and we all knew then the funding was desperately needed. If a company can see the potential in GDR then I agree they would push to partake in a placing at the lowest level possible. Well, it didn't happen. I get the feeling Cheek wants RF out once he's got the good news he wants released and the sp at least a little higher than current levels. I can see a placing at 5p and that's why I've not gone in with too much today. It won't happen over night but come July I really do wonder how high the sp could reach.

Imagine if FDA partner is announced tomorrow. Sp will kick on massively from here and then a placing done at 20p for £5m. Boot RF out the door and then sit back relax and watch it climb all the way past 50p. Will take a few months but certainly worth the wait.

Is GDR expecting two lots of news from NICE in July? I thought it was for CYP2C19? I'm hoping for the NICE recommendation for AIHL to be upgraded to FULL but sometime this year. I am expecting NICE recommendation in July for CYP2C19 (this being delayed from earlier this year) but not sure if it's going to be 'Conditional' or 'Full'. Any ideas anyone?